Add to ORKGThe impact of a reform that increased consumer information on brand name and generic pharmaceutical prices is analyzed both theoretically and empirically. The theoretical results show that an increase in infor-mation likely reduces the price of brand name pharmaceuticals, while the results regarding generics are less clear. In the empirical part of the paper, the introduction of the substitution reform in the Swedish pharmaceuti-cals market in October 2002 is used as a natural experiment regarding the effects of increased consumer information on pharmaceutical prices. The results clearly show that the reform has lowered the price of both brand name and generic pharmaceuticals. Key Words: pharmaceutical industry; generic competition; generic...
In this paper we study the impact of reference pricing (RP) on entry of generic firms in the pharma...
Empirical studies suggest that entry of generic competitors results in minimal decreases or even inc...
This paper examines the price effects of generic drugs that are produced by brand-name drug firms an...
In this paper, the impact of increased information on brand name and generic pharmaceutical prices i...
In this paper, the impact of increased consumer information on brand name and generic pharmaceutical...
The price effects of the Swedish pharmaceutical substitution reform are analyzed using data for a pa...
The price effects of the Swedish pharmaceutical substitution reform are analyzed using data for a pa...
In October 2002 a substitution reform was introduced in the Swedish Pharmaceuticals market. In this ...
The present paper evaluates the quantitative impact of a pharmaceutical reform on pharmaceutical pr...
We study the impact of regulatory regimes on generic competition and pharmaceutical pricing using a ...
In 2009, the Swedish pharmaceuticals market was reformed. One of the stated policygoals was to achie...
In this paper we study the impact of reference pricing (RP) on entry of generic firms in the pharmac...
We study the impact of regulation on competition between brand-names and generics and pharmaceutical...
The aim of this paper is to analyse empirically entry decisions by generic firms into markets with t...
In 2009 the governmental monopoly on the Swedish pharmaceutical market was abolished. Coinciding wit...
In this paper we study the impact of reference pricing (RP) on entry of generic firms in the pharma...
Empirical studies suggest that entry of generic competitors results in minimal decreases or even inc...
This paper examines the price effects of generic drugs that are produced by brand-name drug firms an...
In this paper, the impact of increased information on brand name and generic pharmaceutical prices i...
In this paper, the impact of increased consumer information on brand name and generic pharmaceutical...
The price effects of the Swedish pharmaceutical substitution reform are analyzed using data for a pa...
The price effects of the Swedish pharmaceutical substitution reform are analyzed using data for a pa...
In October 2002 a substitution reform was introduced in the Swedish Pharmaceuticals market. In this ...
The present paper evaluates the quantitative impact of a pharmaceutical reform on pharmaceutical pr...
We study the impact of regulatory regimes on generic competition and pharmaceutical pricing using a ...
In 2009, the Swedish pharmaceuticals market was reformed. One of the stated policygoals was to achie...
In this paper we study the impact of reference pricing (RP) on entry of generic firms in the pharmac...
We study the impact of regulation on competition between brand-names and generics and pharmaceutical...
The aim of this paper is to analyse empirically entry decisions by generic firms into markets with t...
In 2009 the governmental monopoly on the Swedish pharmaceutical market was abolished. Coinciding wit...
In this paper we study the impact of reference pricing (RP) on entry of generic firms in the pharma...
Empirical studies suggest that entry of generic competitors results in minimal decreases or even inc...
This paper examines the price effects of generic drugs that are produced by brand-name drug firms an...